DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Temodar (Temozolomide) - Neoplasm Progression - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neoplasm Progression (7)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Temodar (Temozolomide) where reactions include neoplasm progression. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Temodar side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-25

Patient:

Reactions: Neoplasm Progression

Drug(s) suspected as cause:
Temodar

Other drugs received by patient: Bevacizumab



Possible Temodar side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Neoplasm Progression

Drug(s) suspected as cause:
Temodar



Possible Temodar side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Neoplasm Progression

Drug(s) suspected as cause:
Temodar



Possible Temodar side effects in

Reported by a physician from United States on 2012-08-10

Patient:

Reactions: Neoplasm Progression

Drug(s) suspected as cause:
Temodar



Possible Temodar side effects in

Reported by a physician from United States on 2012-08-10

Patient:

Reactions: Neoplasm Progression

Drug(s) suspected as cause:
Temodar



Possible Temodar side effects in

Reported by a physician from China on 2012-08-10

Patient:

Reactions: Neoplasm Progression

Drug(s) suspected as cause:
Temodar



Possible Temodar side effects in 44 year old male

Reported by a physician from United States on 2012-05-10

Patient: 44 year old male, weighing 110.0 kg (242.0 pounds)

Reactions: Glioblastoma Multiforme, Pancreatitis Acute, Blood Bilirubin Increased, Blood Pressure Increased, Hyperglycaemia, Blood Albumin Decreased, Neoplasm Progression, Cholelithiasis, Haemoglobin Decreased, Blood Calcium Decreased, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: 1230 mg;qow;iv ; 1230 mg;qow;iv
    Indication: Glioblastoma Multiforme
    Start date: 2007-09-10
    End date: 2007-10-08

Avastin
    Dosage: 1230 mg;qow;iv ; 1230 mg;qow;iv
    Indication: Glioblastoma Multiforme
    Start date: 2007-10-29
    End date: 2007-10-29

Temodar
    Dosage: 50 mg/m2;qd;po ; 50 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2007-10-29
    End date: 2007-11-02

Temodar
    Dosage: 50 mg/m2;qd;po ; 50 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2007-09-10
    End date: 2007-10-13

Other drugs received by patient: Hydrochlorothiazide; Decadron; Diflucan; Baclofen; Flexeril; Colace; Zestril; Nexium; Ambien; Viokase 16; Protonix; Miralax; Xanax; Lexapro; Actigall; Lantus

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017